GlassScriptPhysician profile
Robert Barry Lurate
NPI 1033118799
$20,437.53
in general payments reported to CMS, 2019-2025
46 companies · $5,849 in 2025
The $5,849 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $345 · 2021: $843 · 2022: $941 · 2023: $6,282 · 2024: $5,837 · 2025: $5,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Food and Beverage: $2,282 · Travel and Lodging: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,875.22 |
| Food and Beverage | $2,281.75 |
| Travel and Lodging | $1,810.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $13,875.22 | 2023-2025 | Djo Surgical |
| Stryker Corporation | $2,304.78 | 2024-2025 | Mako, Inspace |
| Zimmer Biomet Holdings, INC. | $532.87 | 2020-2021 | |
| Radius Health, INC. | $380.87 | 2020-2025 | Tymlos |
| Depuy Synthes Sales INC. | $378.65 | 2019-2025 | Na, Tfn-Advance, Monovisc |
| Becton, Dickinson and Company | $300.00 | 2022 | |
| Amgen INC. | $227.08 | 2019-2023 | Evenity, Prolia |
| Mimedx Group, INC. | $196.08 | 2024-2025 | |
| Smith+Nephew, INC. | $183.95 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, N/A, Na |
| Si-Bone, INC. | $147.07 | 2020-2024 | |
| Zimvie INC. | $142.07 | 2022-2023 | |
| Medacta USA, INC. | $138.63 | 2025 | Gmk Sphere |
| Abbott Laboratories | $138.01 | 2019-2025 | Eterna |
| Microport Orthopedics INC | $112.35 | 2023-2024 | Mpo Medial Pivot Knee |
| Kci USA, INC. | $109.54 | 2021-2023 | V.A.C. Veraflo |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $103.82 | 2021-2025 | Cmf |
| Tela Bio, INC. | $101.58 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Nuvasive, INC. | $95.64 | 2022 | |
| Cgg Medical INC | $94.86 | 2024 | |
| Cerapedics INC. | $79.81 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Nevro Corp. | $78.88 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $59.23 | 2023-2025 | Libtayo |
| Bioventus LLC | $57.76 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Kerecis Limited | $45.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Vericel Corporation | $40.84 | 2020-2022 | |
| Trilliant Surgical LLC. | $40.19 | 2023 | 3s Hemi Implant, Large, Non-Sterile |
| Medtronic, INC. | $39.03 | 2024 | Medtronic Reusable Instruments, Ligasure |
| Abbvie INC. | $36.87 | 2019 | |
| Boston Scientific Corporation | $36.52 | 2024 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $35.00 | 2025 | Exparel |
| Sanofi-Aventis U.S. LLC | $34.49 | 2019-2020 | |
| Spinal Simplicity, LLC | $30.81 | 2024 | Ha Minuteman G3-R |
| Heraeus Medical, LLC. | $29.75 | 2022-2024 | |
| Davol INC. | $23.56 | 2023 | Phasix Mesh |
| Spinal Elements, INC. | $21.82 | 2024 | |
| Acell, INC. | $20.61 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $20.60 | 2024 | Crysvita |
| Baxter Healthcare | $19.61 | 2019 | |
| Horizon Therapeutics Plc | $18.17 | 2019 | |
| Ethicon US, LLC | $16.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.87 | 2022 | |
| Hologic Sales and Service, LLC | $15.76 | 2025 | Sentimag |
| Orthofix Medical, INC. | $15.20 | 2022 | |
| Csl Behring | $14.65 | 2019 | |
| Centinel Spine, LLC | $14.51 | 2019 | |
| Terumo Bct, INC. | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lurate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.